Table 1 Clinical outcomes
Group A (CoC) | Group B (CoP) | p | 95% CI | |
|---|---|---|---|---|
Hoos – S | 83.0 (SD 15.4) | 90.3 (SD 12.1) | 0.04* | 0.33 to 15.59 |
HOOS – P | 85.5 (SD 11.8) | 91.4 (SD12.9) | 0.052 | −0.04 to 13.06 |
HOOS – SP | 79.4 (SD 23.7) | 79.4 (SD 23.7) | 0.08 | −1.51 to 24.03 |
HOOS – A | 77.9 (SD 17.7) | 86.8 (SD 17.7) | 0.06 | −0.46 to 20.52 |
HOOS – TOTAL | 79 (SD 16) | 87 (SD 16) | 0.04* | 0.24 to 17.90 |
SF-12 P | 39.7 (SD 11.0) | 48.1 (SD 10.1) | 0.02* | 3.60 to 15.03 |
SF-12 M | 46.1 (SD 11.3) | 49.8 (SD 8.6) | 0.14 | −1.13 to 9.97 |